| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_213e7b98bce3a9d6be9936049694fa1a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
| filingDate |
2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f96c97c97ad2cbb7a06bbf68aec33e34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe0c9464431e80f41b8b11b4ec26f98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1563a7ec462872e0baa525f736718a79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1764c9ca12b970c7f4df5477241b6934 |
| publicationDate |
2011-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0620243-A2 |
| titleOfInvention |
chimeric peptide capable of binding to at least one allele form of the hla-dr molecule, pharmaceutical composition and use of the peptide |
| abstract |
<UM> CHEMICAL PEPTIDE CAPABLE OF BINDING AT LEAST ONE ALLELIC FORM OF THE HLA-DR MOLECULE, PHARMACEUTICAL COMPOSITION AND USE OF THE PEPTIDE. <MV> The present invention relates to a chimeric peptide, capable of binding at least one allele form of the HLA-DR molecule. The invention also relates to a pharmaceutical composition containing said peptide, as well as to its different uses. |
| priorityDate |
2005-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |